Physician profile
Robert C Mckoy
NPI 1790779189
$10,121.05
in general payments reported to CMS, 2019-2025
36 companies · $791 in 2025
The $791 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $1,299 · 2021: $1,950 · 2022: $1,559 · 2023: $1,671 · 2024: $1,052 · 2025: $791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,513.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,590.03 | 2019-2025 | |
| Boston Scientific Corporation | $1,399.47 | 2019-2025 | Watchman Flx, General - Therapies, Watchman Access System |
| Janssen Pharmaceuticals, INC | $1,368.55 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,048.95 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $615.05 | 2019-2023 | Brilinta, Farxiga |
| E.R. Squibb & Sons, L.L.C. | $508.19 | 2019-2024 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $495.62 | 2021-2025 | Verquvo |
| Amgen INC. | $449.56 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $445.06 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $380.40 | 2019-2023 | Jardiance |
| Scpharmaceuticals INC. | $288.64 | 2023-2025 | |
| Kestra Medical Technology Services, INC. | $199.69 | 2025 | Assure Wcd |
| Abbott Laboratories | $198.92 | 2020-2025 | Diamondback Coronary |
| G Medical Diagnostic Services, INC. | $137.83 | 2020-2021 | |
| Novo Nordisk INC | $111.55 | 2024-2025 | Ozempic |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $94.67 | 2021-2024 | |
| Baxter Healthcare | $78.28 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Gilead Sciences, INC. | $70.54 | 2019 | |
| Teleflex LLC | $68.77 | 2022-2023 | Guideliner |
| Celonova Biosciences, INC. | $61.48 | 2019-2020 | |
| Terumo Medical Corporation | $55.57 | 2019-2020 | |
| Amarin Pharma, INC. | $55.01 | 2020-2021 | |
| Bardy Diagnostics, INC. | $49.00 | 2020-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $46.71 | 2023 | Arcalyst |
| Portola Pharmaceuticals, LLC | $44.73 | 2019 | |
| Pfizer INC. | $34.92 | 2023-2024 | |
| Arbor Pharmaceuticals, INC. | $32.15 | 2019 | |
| Abiomed | $31.32 | 2023 | Impella |
| Medtronic, INC. | $29.04 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $28.73 | 2019-2021 | |
| Medtronic Vascular, INC. | $26.91 | 2019-2020 | |
| Lundbeck LLC | $18.10 | 2019 | |
| Cardiovascular Systems INC. | $17.74 | 2021 | |
| Preventice Services, LLC | $14.94 | 2021 | |
| Allergan, INC. | $14.05 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mckoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.